Fast Fact Sheet for Protocol 0209 (endometrial) Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer Source Form: NCI FormBuilder:

  1. 8/27/12 8/27/12 -
  2. 1/9/15 1/9/15 - Martin Dugas
  3. 1/9/15 1/9/15 - Martin Dugas
Uploaded on:

January 9, 2015

To request one please log in.
License :
Creative Commons BY-NC 3.0 Legacy
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Endometrial Cancer NCT00063999 Eligibility - Fast Fact Sheet for Protocol 0209 (endometrial) - 2770341v1.0

No Instruction available.

  1. StudyEvent: Fast Fact Sheet for Protocol 0209 (endometrial)
    1. No Instruction available.
Tracking Information
Method of Payment
Module 1
Patient signed consent
Has the patient provided written authorization permitting release of personal health information
What is the site of the disease
What is the cell type
Histologic Grade (Differentiation)
Was the recurrence diagnosed histologically
Is there potential for cure by radiation and/or surgery
Does the patient have measurable disease
Is the measurable disease >= 20 mm when measured by conventional techniques, including palpation, plain X-ray, CT and MRI or >=10mm when measured by spiral CT
Is estrogen receptor and progesterone receptor status of the primary tumor available
Lab Results
Prior Radiation Therapy
Was external beam RT delivered to the pelvis
Was external beam RT delivered to the peri-aortic lymph node region or to the abdomen
Did the patient have intracavitary radiation therapy to the vagina
Have at least 4 weeks elapsed since completion of radiation therapy if it involved the whole pelvis or more than 50% of the spine
Lab Results:
Is the Serum Creatinine less than or equal to ULN
Is SGPT (ALT) less than or equal to 3 X Upper Limits of Normal
Is Bilirubin less than or equal to institutional upper limit of normal
Will the patient have the following paramenters measured within 14 days prior to initiating protocol therapy
Will the patient have the following parameters measured within 28 days prior to initiating protocol therapy
Has the patient had an EKG
Performance Status
Has the patient met the pre-entry requirements as specified in section 7.0
Does the patient have a concomitant malignancy other than non-melanoma skin cancer
Has the patient had any prior cancer diagnosed?
Has the patient been disease-free for 5 or more years and had no prior chemotherapy for previous malignancy
Does the patient have third-degree or complete heart block
Is a pacemaker in place
Does the patient have a chronic disease
Does the patient have a history of myocardial infarction within 6 months before enrollment, New York Heart Association (NYHA) Class II or greater heart failure or symptoms suspicious for congestive heart failure
Has the patient had a left ventricular ejection fraction in the past 6 months that is documented to be 50% or greater
Has the patient had an LVEF of less than 50% in the last 6months
Are there circumstances that will not permit patient to complete therapy or adequate follow-up
Is the patient sensitive to E. Coli-derived drug preparations
Is the patient age 18 years or older

Similar models

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial